Medicine and Dentistry
Dermatology
100%
Male Type Alopecia
80%
Thrombocyte Rich Plasma
64%
Cosmetics
53%
Clinician
41%
Alopecia Mucinosa
39%
Surgeon
38%
Dermatological Agent
37%
Alopecia Areata
35%
Retrospective Study
34%
Restylane
34%
Tattoo
34%
Platelet
30%
Growth Factor
27%
Side Effect
27%
Quality of Life
25%
Low Level Laser Therapy
22%
Patient Satisfaction
22%
Scalp
22%
Melanoma
22%
Systemic Therapy
21%
Neoplasm
20%
Rejuvenation
20%
Photochemotherapy
20%
Cosmetic
20%
Transdermal Drug Administration
19%
Cross Sectional Study
19%
Patient Care
18%
COVID-19
18%
Medical Student
17%
Systematic Review
17%
Drug Administration
17%
Lentigo Maligna
17%
Dermatoscopy
17%
Histopathology
17%
Psoriasis
17%
Telemedicine
17%
Clinical Research
17%
Irritant Dermatitis
17%
Phaeohyphomycosis
17%
Immunotherapy
17%
Lipodystrophy
17%
Rhinophyma
17%
Voriconazole
17%
Hidradenitis Suppurativa
17%
Compression Therapy
17%
Pityriasis Rubra Pilaris
17%
Lactic Acid
17%
Adverse Effect
17%
Coronavirinae
17%
Keyphrases
Androgenetic Alopecia
76%
Platelet-rich Plasma
65%
Alopecia
57%
Alopecia Areata
54%
Photobiomodulation
51%
Hair Loss
49%
Surgeons
42%
Dermatologist
34%
Cosmetic Dermatology
34%
Medical Students
34%
Platelets
30%
Hyaluronic Acid Filler
28%
Safety Profile
28%
Growth Factors
27%
Low-dose Oral Minoxidil
25%
Patient Satisfaction
22%
Systemic Therapy
21%
Skin Rejuvenation
20%
Hair Regeneration
20%
Photodynamic Therapy
19%
Transcutaneous Drug Delivery
19%
Aftercare
19%
Resident Trainees
19%
Dermatology Workforce
18%
Hair Growth
18%
Treatment Options
18%
Popular
17%
Health-related Quality of Life
17%
Pathophysiology
17%
Treatment Algorithm
17%
Adverse Effects
17%
Hyaluronic Acid
17%
Position Statement
17%
Granular Structure
17%
Patient Care
17%
Dermatology Education
17%
Crowdsourcing
17%
Cutaneous T-cell Lymphoma
17%
New Classification
17%
Full-thickness Eyelid Defects
17%
Hair Cosmetics
17%
Dermoscopy
17%
Hidradenitis Suppurativa
17%
Hyaluronic Acid Injection
17%
Classification Schema
17%
Tofacitinib
17%
Patient Preference
17%
Home-use Device
17%
Atypical Fibroxanthoma
17%
Poly(L-lactic acid)
17%
